Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.52 Billion | 1.73 Billion | 1.55 Billion | 1.31 Billion | 1.43 Billion | 1.51 Billion |
| Cost of Revenue | 477.7 Million | 580.95 Million | 436.53 Million | 362.44 Million | 419.83 Million | 435.45 Million |
| Gross Profit | 1.04 Billion | 1.15 Billion | 1.11 Billion | 952.9 Million | 1.01 Billion | 1.07 Billion |
| Operating Expenses | 423.09 Million | 332.08 Million | 333.64 Million | 283.5 Million | 360.81 Million | 380.4 Million |
| Selling, General and Administrative Expenses | 410.29 Million | 341.68 Million | 341.68 Million | 307.77 Million | 363.92 Million | 381.48 Million |
| Research and Development Expenses | 12.2 Million | 7.69 Million | 11.27 Million | 9.46 Million | 13.51 Million | 18.54 Million |
| Other Expenses | 596 Thousand | -9.59 Million | -8.03 Million | -24.27 Million | -3.11 Million | -1.07 Million |
| Cost and Expenses | 900.79 Million | 913.04 Million | 770.17 Million | 645.94 Million | 780.64 Million | 815.85 Million |
| Operating Income | 624.14 Million | 811.57 Million | 778.46 Million | 669.4 Million | 651.98 Million | 698.01 Million |
| Interest Expense | 5.97 Million | 4.66 Million | 4.7 Million | 4.3 Million | 4.2 Million | 19 Thousand |
| Income Tax Expense | 97.2 Million | 134.66 Million | 126.84 Million | 118.01 Million | 112.37 Million | 119.57 Million |
| Earnings before Tax | 691.04 Million | 825.96 Million | 778.39 Million | 685.89 Million | 689.22 Million | 720.89 Million |
| Net Income | 540.39 Million | 645.87 Million | 607.83 Million | 542.45 Million | 556.11 Million | 580.72 Million |
| Earnings Per Share Basic | 0.65 | 0.77 | 0.73 | 0.65 | 0.66 | 0.69 |
| Earnings Per Share Diluted | 0.65 | 0.77 | 0.73 | 0.65 | 0.66 | 0.69 |
| Weighted Average Shares Outstanding | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Gross Margin | 0.69 | 0.66 | 0.72 | 0.72 | 0.71 | 0.71 |
| EBIT Margin | 0.51 | 0.53 | 0.55 | 0.58 | 0.54 | 0.50 |
| Profit Margin | 0.35 | 0.37 | 0.39 | 0.41 | 0.39 | 0.38 |
| EBITDA | 779.54 Million | 907.63 Million | 852.8 Million | 769.14 Million | 774.64 Million | 728.31 Million |
| Earnings Before Tax Margin | 0.41 | 0.47 | 0.50 | 0.51 | 0.46 | 0.46 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 332.25 Million | 332.25 Million | 356.06 Million | 1.52 Billion | 356.06 Million | 406.4 Million |
| Cost of Revenue | 106.37 Million | 106.37 Million | 85.97 Million | 477.7 Million | 85.97 Million | 152.87 Million |
| Gross Profit | 225.88 Million | 225.88 Million | 270.09 Million | 1.04 Billion | 270.09 Million | 253.52 Million |
| Operating Expenses | 96.44 Million | 96.44 Million | 123.04 Million | 431.47 Million | 123.47 Million | 89.69 Million |
| Selling, General and Administrative Expenses | 98.39 Million | 98.39 Million | 125.76 Million | - | 125.76 Million | 89.97 Million |
| Research and Development Expenses | - | - | 6.1 Million | - | 6.1 Million | - |
| Other Expenses | -1.95 Million | -1.95 Million | -8.82 Million | 3.65 Million | - | - |
| Cost and Expenses | 202.82 Million | 202.82 Million | 209.01 Million | 909.17 Million | 209.45 Million | 242.57 Million |
| Operating Income | 129.43 Million | 129.43 Million | 147.05 Million | 615.76 Million | 146.13 Million | 165.01 Million |
| Interest Expense | - | - | 3.3 Million | 5.97 Million | - | 2.66 Million |
| Income Tax Expense | 21.64 Million | 21.64 Million | 20.55 Million | 97.2 Million | 20.55 Million | 28.04 Million |
| Earnings before Tax | 141.82 Million | 141.82 Million | 166.91 Million | 691.04 Million | 166.91 Million | 176.98 Million |
| Net Income | 109.89 Million | 109.89 Million | 137.17 Million | 540.39 Million | 137.17 Million | 133.02 Million |
| Earnings Per Share Basic | 0.13 | 0.13 | 0.16 | - | 0.16 | 0.16 |
| Earnings Per Share Diluted | 0.13 | 0.13 | 0.16 | - | 0.16 | 0.16 |
| Weighted Average Shares Outstanding | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million | 837.1 Million |
| Gross Margin | 0.68 | 0.68 | 0.76 | 0.69 | 0.76 | 0.62 |
| EBIT Margin | 0.40 | 0.40 | 0.42 | - | 0.42 | 0.42 |
| Profit Margin | 0.33 | 0.33 | 0.39 | 0.35 | 0.39 | 0.33 |
| EBITDA | 134.09 Million | 134.09 Million | 150.45 Million | - | 150.45 Million | 169.02 Million |
| Earnings Before Tax Margin | 0.39 | 0.39 | 0.41 | 0.40 | 0.41 | 0.41 |
L&E
INCON
BGTTF
CAPRIHANS
600604
NYMTZ